Downregulation of WIF-1 and Wnt5a in patients with colorectal carcinoma: clinical significance

Downregulation of WIF-1 and Wnt5a in patients with colorectal carcinoma: clinical significance
复制标题

DOI:
10.1007/s13277-014-2015-9
复制
发表时间:
2014-08-01
期刊:
影响因子:
--
通讯作者:
Mokdad-Gargouri, Raja
Mokdad-Gargouri, Raja
中科院分区:
其他
文献类型:
--
作者:
Abdelmaksoud-Dammak, Rania;Miladi-Abdennadher, Imen;Mokdad-Gargouri, Raja

文献摘要

被引文献

相似文献

无翅型(Wnt)信号通路的激活在包括结直肠癌(CRC)在内的各种人类癌症中是常见的。Wnt抑制因子-1(WIF-1)是一种分泌型拮抗剂,可与Wnt配体结合,从而抑制Wnt信号通路。在这项研究中,我们的目的是分析两个成员的Wnt信号(WIF-1和Wnt 5a)在突尼斯散发性大肠癌患者的表达。WIF-1在肿瘤组织中的甲基化率为87.95%,而在正常粘膜中的甲基化率为39.54%,且与远处转移和血管浸润相关(P分别为0.001和0.037)。WIF-1启动子的非甲基化特征在总生存期方面为患者带来益处(P log rank = 0.024)。此外,在WIF-1启动子甲基化的患者组中,肿瘤尺寸小(< 5 cm)且无远处转移的患者的总体生存率显著延长(P log rank分别为0.007和0.036)。WIF-1启动子的异常CpG甲基化导致肿瘤组织中该肿瘤抑制基因的转录沉默(P = 0.001)。此外,我们还发现,与正常组织相比,肿瘤组织中Wnt 5a mRNA的水平显著降低(P = 0.031),并且在表现出更多侵袭性行为(存在淋巴结和晚期TNM分期)的组织中更低。我们的发现支持WIF-1经常甲基化,Wnt 5a在CRC中作为肿瘤抑制基因。WIF-1和Wnt 5a功能的丧失导致疾病的更具侵略性的行为。
Activation of the wingless-type (Wnt) signaling pathway is common in various human cancers including colorectal cancer (CRC). Wnt inhibitory factor-1 (WIF-1) is a secreted antagonist that can bind Wnt ligands and therefore inhibits the Wnt signaling pathway. In this study, we aimed to analyze the expression of two members of Wnt signaling (WIF-1 and Wnt5a) in Tunisian patients with sporadic CRC. WIF-1 was frequently methylated in tumor tissues (87.95 %) compared to normal mucosa (39.54 %) and correlated with distant metastasis and vascular invasion (P = 0.001 and 0.037, respectively). The unmethylated profile of the WIF-1 promoter conferred a benefit to patients in terms of overall survival (P log rank = 0.024). In addition, in the group of patients with methylated WIF-1 promoter, the overall survival rate was significantly prolonged for those with small tumor size (< 5 cm) and absence of distant metastasis (P log rank = 0.007 and 0.036, respectively). Aberrant CpG methylation of the WIF-1 promoter leads to transcriptional silencing of this tumor suppressor gene in tumor tissues (P = 0.001). Furthermore, we showed that the level of Wnt5a mRNA was significantly lower in tumor compared to normal tissues (P = 0.031) and lower still in those showing more aggressive behavior (presence of lymph nodes and advanced TNM stage). Our finding supports that WIF-1 is frequently methylated and that Wnt5a acts as a tumor suppressor gene in CRC. Loss of WIF-1 and Wnt5a functions results in more aggressive behavior of the disease.